Ryzodeg Listing on the PBS statement
Diabetes Australia applauds the decision by Health Minister Greg Hunt and the Federal Government to list Ryzodeg on the Pharmaceutical Benefits Scheme (PBS) from 30 July 2018.
Ryzodeg is a combination of ultra-long acting and rapid-acting insulin delivered in a once-daily injection that will eliminate the need for multiple daily injections and make diabetes management easier and less intrusive for some people.
Insulin injections are one of the most intrusive parts of living with diabetes. All people living with type 1 diabetes who are not using insulin pumps and many people with type 2 diabetes have to inject themselves with insulin multiple times during the day.